Mifomelatide
(3S,11S,14S,17S,20R,23S)-3-[[(2S)-2-acetamidohexanoyl]amino]-N-[1-[(2R)-2-carbamoylpyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]-17-[3-(diaminomethylideneamino)propyl]-14-(1H-indol-3-ylmethyl)-20-(naphthalen-2-ylmethyl)-2,5,13,16,19,22-hexaoxo-1,6,12,15,18,21-hexazabicyclo[21.3.0]hexacosane-11-carboxamide
Molecular Identity
Mifomelatide
(3S,11S,14S,17S,20R,23S)-3-[[(2S)-2-acetamidohexanoyl]amino]-N-[1-[(2R)-2-carbamoylpyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]-17-[3-(diaminomethylideneamino)propyl]-14-(1H-indol-3-ylmethyl)-20-(naphthalen-2-ylmethyl)-2,5,13,16,19,22-hexaoxo-1,6,12,15,18,21-hexazabicyclo[21.3.0]hexacosane-11-carboxamide
PubChem CID: 169450720
2D Structure
Properties
C63H87N15O11
Molecular Formula
1230.50
Molecular Weight
g/mol
1229.6709
Exact Mass
Da
2.6
XLogP
Drug-like (Lipinski: < 5)
397
TPSA
May have limited oral absorption
12
H-Bond Donors
12
H-Bond Acceptors
2530
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(6)
MifomelatideTCMCB071456699-27-6MBDALAXLRYJVAO-YIHQDKBISA-NHY-P5971CS-0900828
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Mifomelatide
Loading drug network...